ESMO 2017: News Articles

Interested in what happened during the ESMO 2017 Congress?

Read our news articles here

Date Title Topic
10 Sep 2017 ESMO 2017: Combined Abemaciclib with NSAI Show Significant Clinical Benefit as Initial Treatment for Patients with HR-positive/HER2-negative ABC at Interim Analysis Breast cancer - Anticancer agents & Biologic therapy
10 Sep 2017 ESMO 2017: Ramucirumab Improves PFS in Patients with Platinum Refractory Advanced Urothelial Carcinoma Genitourinary cancers - Anticancer agents & Biologic therapy
10 Sep 2017 ESMO 2017: Biomarker Analysis Reveals Different Genes are Upregulated After Lenvatinib and Sorafenib Treatment in Unresected HCC Gastrointestinal cancers - Translational research
10 Sep 2017 ESMO 2017: Biosimilar Rituximab Shows Equivalent Efficacy to Reference Rituximab in Previously Untreated Advanced Follicular Lymphoma Haematologic malignancies - Anticancer agents & Biologic therapy
10 Sep 2017 ESMO 2017: Patients Receiving Radioactive Iodine for Well-Differentiated Thyroid Cancer Have an Increased Risk of AML Haematologic malignancies
10 Sep 2017 ESMO 2017: Strong Association Exists Between Tumour Type and Survival in Early Breast Cancer Breast cancer
10 Sep 2017 ESMO 2017: Genomic Landscape of Patients with TNBC and Disease Recurrence Investigated Breast cancer - Translational research
09 Sep 2017 ESMO 2017: Front-Line Osimertinib Poised to Become Standard of Care in EGFR-Mutation Positive NSCLC Lung and other thoracic tumours - Personalised medicine - Anticancer agents & Biologic therapy
09 Sep 2017 ESMO 2017: Durvalumab as Consolidation Therapy Prolongs PFS in Stage III NSCLC Patients Without Progression Following Platinum-based Chemoradiotherapy Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
09 Sep 2017 ESMO 2017: Large Dataset of Targetable Genomic Alterations Created Using Liquid Biopsy Translational research
09 Sep 2017 ESMO 2017: Subtypes of Thymic Carcinomas Show Different Genomic Alterations and Tumour Mutational Burden Endocrine and neuroendocrine tumours - Translational research
09 Sep 2017 ESMO 2017: Tumour Subtype Specific Genetic Alterations Detected by Comprehensive Genomic Profiling Translational research
09 Sep 2017 ESMO 2017: Sub-study of the GAND-Emesis Trial with Neurokinin-1 Receptor Antagonist During Concomitant Chemoradiotherapy for Cervical Cancer Palliative and supportive care
09 Sep 2017 ESMO 2017: Clinical Trial Toxicity Reporting by Investigators May Not Reflect Patients’ Viewpoint Palliative and supportive care
09 Sep 2017 ESMO 2017: Adjuvant Imatinib Recommended Only for Patients with High-risk GIST Sarcomas - Anticancer agents & Biologic therapy